USPTO serial 98797472
OBIGAIL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JANSON, ANDREW KYLE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with OBIGAIL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New York, NY, US
New York, NY, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark A. Jansen
801 California StreetMountain View, CA 94041United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations for the treatment of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Pharmaceuticals for the management of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications | ACTIVE | — |
| 041 | Training services in the field of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Educational services, namely, conducting classes, seminars, conferences, and workshops in the field of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; providing online non-downloadable articles, scientific papers, journals, brochures, leaflets, guides, manuals, videos, and multimedia content in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software using artificial intelligence (AI) for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; software as a service (SAAS) services featuring software using agentic artificial intelligence (AI) for providing digital health services; software as a service (SAAS) services featuring software using agentic artificial intelligence (AI) for sending and receiving electronic messages, graphics, images, audio and audio visual content between healthcare professionals and individuals; Providing temporary use of online non-downloadable software using artificial intelligence (AI) for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; Software as a service (SAAS) services featuring software for the provision of healthcare services; Providing temporary use of online non-downloadable software for use in connecting patients with health counseling providers, therapists, medical support resources, and information regarding treatment of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; Providing temporary use of online non-downloadable software for sending and receiving electronic messages, graphics, images, audio and audio visual content between healthcare professionals and individuals; Providing temporary use of online non-downloadable software for facilitating medical consultancy services; Providing temporary use of online non-downloadable software for providing digital health services; Providing temporary use of online non-downloadable software for collecting, processing, and transmitting data between health care providers and patients; Providing temporary use of online non-downloadable software for enabling patients to view upcoming medical procedures, prepare for office visits, request medical tests, schedule and confirm medical appointments, and receive assistance with appointment logistics; Providing temporary use of online non-downloadable software for accessing information in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software using artificial intelligence technology for data analytics for use in connection with health counseling, therapy, support, and treatment; Providing temporary use of online non-downloadable software for managing the provision of healthcare services for use in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software for medical research; Scientific and technological services, namely, research and development in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Research and development of pharmaceuticals | ACTIVE | — |
| 044 | Healthcare services, namely, providing medical treatment in the fields of early pregnancy loss, miscarriage, infertility, and pregnancy complications; Healthcare services, namely, a patient assistance program providing pharmaceuticals for the treatment of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing medical information in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Medical services; Pharmaceutical compounding services; Medical advisory services; Medical consultation and counseling services in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Medical consultations and therapy provided via website, phone, online chat or videoconferencing; Telemedicine services in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Women's health care and wellness services, namely, providing online information related to health care and wellness services; Preparation and dispensing of medications | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Avila Science, Inc.
- Other trademarks owned by Avila Science, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named OBIGAIL
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 10, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 10, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 6, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 15, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 8, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 29, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 15, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 15, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 11, 2024 | NWAP | NEW APPLICATION ENTERED | — |